Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF577 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | TRIM28 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ARMC8 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | DISP3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | RP11-214K3.25 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ARFIP1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | PBXIP1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | CENPP | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | LRRC8E | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
mRNA | ELAVL2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |